Physician profile
Joel Hancock
NPI 1235584533
$4,374.94
in general payments reported to CMS, 2019-2025
18 companies · $2,142 in 2025
The $2,142 reported for 2025 was more than what 81% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $230 · 2022: $1,725 · 2023: $151 · 2024: $128 · 2025: $2,142.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,284 · Travel and Lodging: $1,136.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,283.66 |
| Travel and Lodging | $1,136.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,809.63 | 2021-2025 | Altaviva, Interstim |
| Teleflex LLC | $1,559.44 | 2021-2025 | Urolift, Barrigel |
| Astellas Pharma US INC | $221.39 | 2022 | |
| Boston Scientific Corporation | $215.32 | 2022-2025 | Spaceoar Vue System - 10ml, Lumenis Pulse 120h, Lithovue Elite |
| Abbvie INC. | $137.16 | 2022-2025 | |
| Calyxo, INC. | $58.27 | 2025 | Cvac Aspiration System |
| Urovant Sciences INC | $56.84 | 2022 | |
| 180 Medical, INC. | $53.37 | 2022-2023 | Gentlecath Glide |
| Sumitomo Pharma America, INC. | $48.08 | 2023-2025 | Gemtesa |
| Telix Pharmaceuticals | $41.65 | 2025 | Illuccix |
| Olympus America INC. | $39.00 | 2025 | Itind System |
| Laborie Medical Technologies Corp. | $37.53 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Endo USA, INC. | $25.46 | 2025 | Xiaflex |
| Antares Pharma, INC. | $20.97 | 2022 | |
| Immunitybio, INC. | $16.93 | 2024 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $15.81 | 2025 | |
| Allergan, INC. | $14.27 | 2021 | |
| Travere Therapeutics, INC. | $3.82 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joel Hancock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.